Benzinga | Mar 1, 2021 04:21PM EST

ChemoCentryx Q4 EPS $(0.43) Misses $(0.33) Estimate, Sales $4.36M Miss $7.99M Estimate

ChemoCentryx (NASDAQ:CCXI) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.33) by 30.3 percent. This is a 65.38 percent decrease over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $4.36 million which missed the analyst consensus estimate of $7.99 million by 45.46 percent. This is a 56.62 percent decrease over sales of $10.05 million the same period last year.